Because hormone-negative breast cancers (ER/PR-negative) and HER2-positive breast cancers are more likely to reoccur and spread outside the breast tissue compared to ER/PR-positive breast cancers [47], the effect of ER/PR/HER2 status on plasma levels of miR-200c and miR-141 was evaluated. The gene discussed is ERBB2; the disease is breast cancer.